Cited by 1,828Substance Abuse Treatment and OutcomesAlcohol Consumption and Health EffectsAlcoholism and Thiamine Deficiency

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Naltrexone in the Treatment of Alcohol Dependence

Volpicelli, Joseph R.·1992·Archives of General Psychiatry

DOI 10.1001/archpsyc.1992.01820110040006

Open this paper in CoChat — free account

Abstract

Seventy male alcohol-dependent patients participated in a 12-week, double-blind, placebo-controlled trial of naltrexone hydrochloride (50 mg/d) as an adjunct to treatment following alcohol detoxification. Subjects taking naltrexone reported significantly less alcohol craving and days in which any alcohol was consumed. During the 12-week study, only 23% of the naltrexone-treated subjects met the criteria for a relapse, whereas 54.3% of the placebo-treated subjects relapsed. The primary effect of naltrexone was seen in patients who drank any alcohol while attending outpatient treatment. Nineteen (95%) of the 20 placebo-treated patients relapsed after they sampled alcohol, while only eight (50%) of 16 naltrexone-treated patients exposed to alcohol met relapse criteria. Naltrexone was not associated with mood changes or other psychiatric symptoms. Significant side effects (nausea) occurred in two naltrexone-treated subjects, and one naltrexone-treated subject complained of increased pain from arthritis. These results suggest that naltrexone may be a safe and effective adjunct to treatment in alcohol-dependent subjects, particularly in preventing alcohol relapse.

Integrity signals

Registry

Crossref · 10.1001/archpsyc.1992.01820110040006

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory
Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., & Covi, L. (1974) · Behavioral Science · doi:10.1002/bs.3830190102 · Cited by 4,604
Survival Analysis
Miller, R. G. (1981) · Cited by 3,336
Disulfiram treatment of alcoholism. A Veterans Administration cooperative study
Fuller, R. K. (1986) · JAMA · doi:10.1001/jama.256.11.1449 · Cited by 541
Alteration of ethanol self-administration by naltrexone
Altshuler, H. L., Phillips, P. E., & Feinhandler, D. A. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90257-x · Cited by 397
The Effectiveness of Alcoholism Treatment
Miller, W. R., & Hester, R. K. (1986) · Springer eBooks · doi:10.1007/978-1-4613-2191-0_7 · Cited by 276
The serotonin uptake inhibitor citalopram attenuates ethanol intake
Naranjo, C. A., Sellers, E. M., Sullivan, J. T., Woodley-Remus, D., Kadlec, K. E., & Sykora, K. (1987) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1987.27 · Cited by 236
Naltrexone blocks the post-shock increase of ethanol consumption
Volpicelli, J. R., Davis, M. A., & Olgin, J. E. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90601-6 · Cited by 187
Self-citation
Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey
Myers, R. D., Borg, S., & Mossberg, R. (1986) · Alcohol · doi:10.1016/0741-8329(86)90058-3 · Cited by 167
Lithium Treatment of Depressed and Nondepressed Alcoholics
Dorus, W. (1989) · JAMA · doi:10.1001/jama.1989.03430120100029 · Cited by 164
Oral ethanol self-administration in the rat: Effect of naloxone
Samson, H. H., & Doyle, T. F. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90491-5 · Cited by 162

Show all 23 references

Sorted by citations

Items 401–500 of 1,004

Treatment of Late-Life Depression Complicated by Alcohol Dependence
Oslin, D. W. (2005) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200506000-00008 · Cited by 80
Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA
Abraham, A. J., Andrews, C. M., Harris, S. J., & Friedmann, P. D. (2020) · Neurotherapeutics · doi:10.1007/s13311-019-00814-4 · Cited by 79
Cyclic AMP and ethanol interact to control apoptosis and differentiation in hypothalamic beta-endorphin neurons.
De, A., Boyadjieva, N. I., Pastorcic, M., Reddy, B. V., & Sarkar, D. K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47075-5 · Cited by 78
Increased impulsivity after injected alcohol predicts later alcohol consumption in rats: Evidence for "loss-of-control drinking" and marked individual differences.
Poulos, C. X., Parker, J. L., & Lê, D. A. (1998) · Behavioral Neuroscience · doi:10.1037//0735-7044.112.5.1247 · Cited by 78
Alcohol drinking is reduced by a μ1- but not by a δ-opioid receptor antagonist in alcohol-preferring rats
Honkanen, A., Vilamo, L., Wegelius, K., Sarviharju, M., Hyytiä, P., & Korpi, E. R. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00118-5 · Cited by 74
Naltrexone Depot Formulations for Opioid and Alcohol Dependence: A Systematic Review
Lobmaier, P. P. K., Kunøe, N., Gossop, M., & Waal, H. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00194.x · Cited by 78
The Effect of Naltrexone on Alcohol’s Stimulant Properties and Self‐Administration Behavior in Social Drinkers: Influence of Gender and Genotype
Setiawan, E., Pihl, R. O., Cox, S. M. L., Gianoulakis, C., Palmour, R. M., Benkelfat, C., & Leyton, M. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01446.x · Cited by 76
Craving and relapse measurement in alcoholism.
Potgieter, A. S., Deckers, F., & Geerlings, P. J. (1999) · Alcohol and Alcoholism · doi:10.1093/alcalc/34.2.254 · Cited by 77
Endogenous opioids and excessive alcohol consumption.
Gianoulakis, C. (1993) · PubMed Central · Cited by 73
Single versus multiple drug focus in substance abuse clinical trials research.
Rounsaville, B., Petry, N., & Carroll, K. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00033-4 · Cited by 81
Dose-Ranging Kinetics and Behavioral Pharmacology of Naltrexone and Acamprosate, Both Alone and Combined, in Alcohol-Dependent Subjects
Johnson, B. A., O’Malley, S. S., Ciraulo, D. A., Roache, J. D., Chambers, R. A., Sarid‐Segal, O., & Couper, D. J. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000084029.22282.bb · Cited by 76
NEUROCHEMICAL MARKERS OF ALCOHOLISM VULNERABILITY IN HUMANS
Ratsma, J. E. (2002) · Alcohol and Alcoholism · doi:10.1093/alcalc/37.6.522 · Cited by 76
Extended-Release Naltrexone: A Qualitative Analysis of Barriers to Routine Use
Alanis‐Hirsch, K., Croff, R. L., Ford, J. H., Johnson, K., Chalk, M., Schmidt, L. A., & McCarty, D. W. (2015) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2015.10.003 · Cited by 77
Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study
Caputo, F., Addolorato, G., Lorenzini, F., Domenicali, M., Greco, G., Re, A. D., Gasbarrini, A., Stefanini, G. F., & Bernardi, M. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00340-x · Cited by 77
The effects of alcoholism on the hypothalamic‐pituitary‐adrenal axis: interaction with endogenous opioid peptides
Inder, W. J., Joyce, P. R., Ellis, M. J., Evans, M. J., Livesey, J., & Donald, R. A. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02033.x · Cited by 74
Daidzin inhibits mitochondrial aldehyde dehydrogenase and suppresses ethanol intake of Syrian golden hamsters
Keung, W. M., Klyosov, A. A., & Vallée, B. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1675 · Cited by 76
Role of the Primary Care Physician in Problems of Substance Abuse
Weaver, M. F., Jarvis, M. A. E., & Schnoll, S. H. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.913 · Cited by 76
Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment
Mason, B. J. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.08.009 · Cited by 75
Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work
Kumar, R., Harilal, S., Gupta, S. V., Jose, J., Parambi, D. G. T., Uddin, M. S., Shah, M. A., & Mathew, B. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111602 · Cited by 78
Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescents
Niederhofer, H., & Staffen, W. (2003) · Drug and Alcohol Review · doi:10.1080/0959523031000154436 · Cited by 75
Sudden unexpected death in epilepsy: Risk factors, biomarkers, and prevention
DeGiorgio, C. M., Curtis, A., Hertling, D., & Moseley, B. D. (2018) · Acta Neurologica Scandinavica · doi:10.1111/ane.13049 · Cited by 75
Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism.
Kranzler, H. R., & Anton, R. F. (1994) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.62.6.1116 · Cited by 75
Research Advances in the Understanding and Treatment of Addiction
O’Brien, C. P. (2003) · American Journal on Addictions · doi:10.1111/j.1521-0391.2003.tb00555.x · Cited by 75
The nociceptin/orphanin FQ/NOP receptor system as a target for treatment of alcohol abuse: a review of recent work in alcohol-preferring rats
Ciccocioppo, R., Economidou, D., Fedeli, A., & Massi, M. (2003) · Physiology & Behavior · doi:10.1016/s0031-9384(03)00112-4 · Cited by 74
Evidence-Based Pharmacotherapies for Alcohol Use Disorder
Fairbanks, J., Umbreit, A., Kolla, B. P., Karpyak, V. M., Schneekloth, T. D., Loukianova, L. L., & Sinha, S. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.01.030 · Cited by 75
Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts
Daiwile, A. P., Jayanthi, S., & Cadet, J. L. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104674 · Cited by 75
Clinical uses of naltrexone: A review of the evidence.
Modesto‐Lowe, V., & Kirk, J. V. (2002) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.10.3.213 · Cited by 74
Association of Functional Opioid Receptor Genotypes With Alcohol Dependence in Koreans
Kim, S., Kim, C., Kang, D., Kim, Y., Byun, W., Kim, S., Park, J., Kim, M.-J., & Oslin, D. W. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000130803.62768.ab · Cited by 73
Activation of PPAR γ by Pioglitazone Potentiates the Effects of Naltrexone on Alcohol Drinking and Relapse in ms P Rats
Stopponi, S., de Guglielmo, G., Somaini, L., Cippitelli, A., Cannella, N., Kallupi, M., Ubaldi, M., Heilig, M. A., Demopulos, G. A., Gaitanaris, G., et al. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12091 · Cited by 74
Different alcohol exposures induce selective alterations on the expression of dynorphin and nociceptin systems related genes in rat brain
D’Addario, C., Caputi, F. F., Rimondini, R., Gandolfi, O., Borrello, E. D., Candeletti, S., & Romualdi, P. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00326.x · Cited by 77
The Dual Orexin/Hypocretin Receptor Antagonist, Almorexant, in the Ventral Tegmental Area Attenuates Ethanol Self-Administration
Srinivasan, S., Simms, J. A., Nielsen, C. K., Lieske, S. P., Bito‐Onon, J. J., Yi, H. Y., Hopf, F. W., Bonci, A., & Bartlett, S. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044726 · Cited by 74
Naltrexone in the Treatment of Heroin Dependence: Relationship with Depression and Risk of Overdose
Ritter, A. J. (2002) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2002.01012.x · Cited by 73
Intramuscular extended‐release naltrexone: current evidence
Gastfriend, D. R. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05900.x · Cited by 71
Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers.
Haney, M., Ramesh, D., Glass, A., Pavlicova, M., Bedi, G., & Cooper, Z. D. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.108 · Cited by 73
Nociceptin/Orphanin FQ Blockade of Corticotropin-Releasing Factor-Induced Gamma-Aminobutyric Acid Release in Central Amygdala Is Enhanced After Chronic Ethanol Exposure
Cruz, M. T., Herman, M. A., Kallupi, M., & Roberto, M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.032 · Cited by 72
PRECLINICAL STUDY: Evidence for the role of dopamine D3receptors in oral operant alcohol self‐administration and reinstatement of alcohol‐seeking behavior in mice
Heidbreder, C. A., Andreoli, M., Marcon, C., Hutcheson, D. M., Gardner, E. L., & Ashby, C. R. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00051.x · Cited by 72
Hepatic, Metabolic, and Nutritional Disorders of Alcoholism: From Pathogenesis to Therapy
Lieber, C. S. (2000) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360091174312 · Cited by 72
Genetic analysis of the μ-opioid receptor in alcohol-dependent individuals
Rommelspacher, H., Smolka, M. N., Schmidt, L. G., Samochowiec, J., & Hoehe, M. R. (2001) · Alcohol · doi:10.1016/s0741-8329(01)00139-2 · Cited by 72
Quantitative Autoradiography of Mu-Opioid Receptors in the CNS of Alcohol-Naive Alcohol-Preferring P and -Nonpreferring NP Rats
McBride, W. J., Chernet, E., McKinzie, D. L., Lumeng, L., & Li, T. (1998) · Alcohol · doi:10.1016/s0741-8329(98)00021-4 · Cited by 72
New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments
Lieber, C. S. (2004) · Current Gastroenterology Reports · doi:10.1007/s11894-004-0027-0 · Cited by 72
Background and overview of mental health and substance abuse treatment systems: meeting the needs of women who are pregnant or parenting.
Grella, C. (1996) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1996.10472614 · Cited by 78
Genetics of alcoholism: Role of the endogenous opioid system
Gianoulakis, C., & de Waele, J. (1994) · Metabolic Brain Disease · doi:10.1007/bf01999765 · Cited by 70
The Phosphodiesterase‐4 ( PDE 4) Inhibitor Rolipram Decreases Ethanol Seeking and Consumption in Alcohol‐Preferring Fawn‐Hooded Rats
Wen, R., Zhang, M., Qin, W., Liu, Q., Wang, W., Lawrence, A. J., Zhang, H., & Liang, J. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01845.x · Cited by 75
Basal levels and alcohol-induced changes in nociceptin/orphanin FQ, dynorphin, and enkephalin levels in C57BL/6J mice
Ploj, K., Roman, E., Gustavsson, L., & Nylander, I. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00328-2 · Cited by 71
The role of serotonin in craving: from basic research to human studies.
Ciccocioppo, R. (1999) · Alcohol and Alcoholism · doi:10.1093/alcalc/34.2.244 · Cited by 69
Pharmacogenetics of Naltrexone in Asian Americans: A Randomized Placebo-Controlled Laboratory Study
Ray, L. A., Bujarski, S., Chin, P. F., & Miotto, K. A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.192 · Cited by 71
New achievements and pharmacotherapeutic approaches in the treatment of alcohol dependence
Kiefer, F., & Mann, K. F. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.09.028 · Cited by 70
Current and Promising Pharmacotherapies, and Novel Research Target Areas in the Treatment of Alcohol Dependence: A Review
Edwards, S. M., Kenna, G. A., Swift, R. M., & Leggio, L. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796150765 · Cited by 70
Buspirone in the Treatment of Alcohol Dependence: A Placebo‐Controlled Trial
Malec, E., Malec, T., Gagné, M., & Dongier, M. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01644.x · Cited by 70
Naltrexone Biotransformation and Incidence of Subjective Side Effects: A Preliminary Study
King, A. C., Volpicelli, J. R., Gunduz, M., O’Brien, C. P., & Kreek, M. J. (1997) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1997.tb03856.x · Cited by 70
Self-citation
Pharmacotherapy of Schizophrenia Patients With Comorbid Substance Abuse
WILKINS, J. N. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.2.215 · Cited by 67
Analysis of Heritability of Hormonal Responses to Alcohol in Twins: Beta-Endorphin as a Potential Biomarker of Genetic Risk for Alcoholism
Froehlich, J. C., Zink, R. W., Li, T., & Christian, J. C. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb04607.x · Cited by 69
EFFECTS OF NALTREXONE ON THE ETHANOL-INDUCED CHANGES IN THE RAT CENTRAL DOPAMINERGIC SYSTEM
LEE, Y.-K. (2005) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh163 · Cited by 73
Benzodiazepine receptor ligands modulate ethanol drinking in alcohol-preferring rats
Wegelius, K., Honkanen, A., & Korpi, E. R. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90534-7 · Cited by 70
Downregulation of mu opioid receptor by RNA interference in the ventral tegmental area reduces ethanol consumption in mice
Lasek, A. W., Janak, P. H., He, L., Whistler, J. L., & Heberlein, U. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00303.x · Cited by 70
GABAergic modulation of binge-like ethanol intake in C57BL/6J mice
Moore, E. M., Serio, K. M., Goldfarb, K. J., STEPANOVSKA, S., Linsenbardt, D. N., & Boehm, S. L. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.07.011 · Cited by 69
Pharmacogenetic Treatments for Drug Addiction: Alcohol and Opiates
Haile, C. N., Kosten, T. A., & Kosten, T. R. (2008) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990802122564 · Cited by 73
Efficacy of Buspirone in Alcohol Dependence: A Review
Malec, T., Malec, E. A., & Dongier, M. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb05263.x · Cited by 70
Predictors of Compliance with Naltrexone Among Alcoholics
Rohsenow, D. J., Colby, S. M., Monti, P. M., Swift, R. M., Martin, R. A., Mueller, T. I., Gordon, A. A., & Eaton, C. A. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb04573.x · Cited by 69
Alcoholics Anonymous and the use of medications to prevent relapse: an anonymous survey of member attitudes.
Rychtarik, R. G., Connors, G. J., Dermen, K. H., & Stasiewicz, P. R. (2000) · Journal of Studies on Alcohol · doi:10.15288/jsa.2000.61.134 · Cited by 69
Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: A preliminary study.
Bujarski, S., MacKillop, J. M., & Ray, L. A. (2012) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0027379 · Cited by 69
Late-Life Alcoholism
Oslin, D. W. (2004) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.12.6.571 · Cited by 72
Ethanol‐Induced Change in Cardiac and Endogenous Opiate Function and Risk for Alcoholism
Peterson, J. B., Pihl, R. O., Gianoulakis, C., Conrod, P., Finn, P., Stewart, S. H., LeMarquand, D. G., & Bruce, K. R. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01697.x · Cited by 66
Straight-Chain Naltrexone Ester Prodrugs: Diffusion and Concurrent Esterase Biotransformation in Human Skin
Stinchcomb, A. L., Swaan, P. W., Ekabo, O., Harris, K. K., Browe, J., Hammell, D. C., Cooperman, T. A., & Pearsall, M. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10239 · Cited by 68
Advances in the Use of Naltrexone an Integration of Preclinical and Clinical Findings
O’Malley, S. S., & Froehlich, J. C. (2002) · Springer eBooks · doi:10.1007/0-306-47939-7_17 · Cited by 67
The disease called addiction: emerging evidence in a 200-year debate
Meyer, R. E. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90345-1 · Cited by 67
Does nicotine withdrawal affect smoking cessation? Clinical and theoretical issues
Patten, C. A., & Martin, J. E. (1996) · Annals of Behavioral Medicine · doi:10.1007/bf02883397 · Cited by 67
Opioid Involvement in Alcohol Drinkinga
Froehlich, J. C., & Li, T. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb19817.x · Cited by 67
The anxious amygdala: CREB signaling and predisposition to anxiety and alcoholism
Wand, G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26436 · Cited by 66
Naltrexone Treatment of Adolescent Alcoholics: An Open-Label Pilot Study
Deas, D., May, M. K., Randall, C., Johnson, N., & Anton, R. (2005) · Journal of child and adolescent psychopharmacology · doi:10.1089/cap.2005.15.723 · Cited by 64
Suicide in Alcohol-Dependent Individuals
Pirkola, S. P., Suominen, K. H., & Isomets�, E. (2004) · CNS Drugs · doi:10.2165/00023210-200418070-00002 · Cited by 66
REVIEW: Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone
Oslin, D. W., Berrettini, W. H., & O’Brien, C. P. (2006) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00036.x · Cited by 67
Vivitrex®, an Injectable, Extended-Release Formulation of Naltrexone, Provides Pharmacokinetic and Pharmacodynamic Evidence of Efficacy for 1 Month in Rats
Bartus, R. T., Emerich, D. F., Hotz, J., Blaustein, M., Dean, R. L., Perdomo, B., & Basile, A. S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300274 · Cited by 65
Advances in development of medications for alcoholism treatment
Litten, R. Z., & Allen, J. P. (1998) · Psychopharmacology · doi:10.1007/s002130050686 · Cited by 66
Contribution of the Opioid System to Alcohol Aversion and Alcohol Drinking Behavior
Froehlich, J. C., Badia‐Elder, N. E., Zink, R. W., McCullough, D. E., & Portoghese, P. S. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37789-4 · Cited by 66
Recent developments in the pharmacotherapy of alcohol dependence.
Schuckit, M. A. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.64.4.669 · Cited by 66
Naltrexone: A Pan-Addiction Treatment?
Aboujaoude, E. N., & Salame, W. O. (2016) · CNS Drugs · doi:10.1007/s40263-016-0373-0 · Cited by 64
Naltrexone Dampens Ethanol-Induced Cardiovascular and Hypothalamic- Pituitary-Adrenal Axis Activation
McCaul, M. E. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00241-x · Cited by 65
Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL/6J mice.
Phillips, T. J., Wenger, C. D., & Dorow, J. D. (1997) · PubMed · Cited by 65
Current Pharmacotherapies of Alcoholism: A U.S. Perspective
Anton, R. F., & Swift, R. M. (2003) · American Journal on Addictions · doi:10.1111/j.1521-0391.2003.tb00496.x · Cited by 65
Translational opportunities in animal and human models to study alcohol use disorder
Nieto, S. J., Grodin, E. N., Aguirre, C. G., Izquierdo, A., & Ray, L. A. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01615-0 · Cited by 69
A Placebo‐Controlled Randomized Clinical Trial of Naltrexone in the Context of Different Levels of Psychosocial Intervention
Oslin, D. W., Lynch, K. G., Pettinati, H. M., Kampman, K. M., Gariti, P., Gelfand, L. A., Have, T. T., Wortman, S. P., Dundon, W. D., Dackis, C. A., et al. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00698.x · Cited by 64
Self-citation
Modulation of alcohol and nicotine responses through the endogenous opioid system
Drews, E., & Zimmer, A. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.09.004 · Cited by 66
A Randomized, Double‐Blind, Placebo‐Controlled Trial of Naltrexone in the Treatment of Concurrent Alcohol Use Disorder and Pathological Gambling
Toneatto, T., Brands, B., & Selby, P. L. (2009) · American Journal on Addictions · doi:10.1080/10550490902787007 · Cited by 64
Suicidal behavior, drug use and depressive symptoms after detoxification: a 2-year prospective study.
Wines, J., Saitz, R., Horton, N. J., Lloyd-Travaglini, C., & Samet, J. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.08.004 · Cited by 67
Outpatient Management of Patients with Alcohol Problems
Fiellin, D. A., Reid, M. C., & O'Connor, P. G. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-10-200011210-00015 · Cited by 61
Alterations in Central Preproenkephalin mRNA Expression After Chronic Free-Choice Ethanol Consumption by Fawn-Hooded Rats
Cowen, M. S., & Lawrence, A. J. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02326.x · Cited by 63
Targeted naltrexone treatment of early problem drinkers
Kranzler, H. R., Tennen, H. A., Penta, C., & Bohn, M. J. (1997) · Addictive Behaviors · doi:10.1016/s0306-4603(96)00064-0 · Cited by 64
The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics
Ooteman, W., Koeter, M. W. J., Verheul, R., Schippers, G. M., & van den Brink, W. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.02.012 · Cited by 65
Alcohol and Eating Disorders: Implications for Alcohol Treatment and Health Services Research
Sinha, R., & O’Malley, S. S. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb02097.x · Cited by 64
Naltrexone Blocks Acquisition of Voluntary Ethanol Intake in Rats
Davidson, D., & Amit, Z. (1997) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1997.tb03822.x · Cited by 63
PTSD and comorbid AUD: a review of pharmacological and alternative treatment options
Petrakis, I. L., Ralevski, E., & Olivera-Figueroa, L. A. (2014) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s37399 · Cited by 66
In alcohol-treated rats, naloxone decreases extracellular dopamine and increases acetylcholine in the nucleus accumbens: evidence of opioid withdrawal
Rada, P. V., JOHNSON, D., LEWIS, M., & Hoebel, B. G. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.09.011 · Cited by 64
Effects of Naltrexone Administered Repeatedly Across 30 or 60 Days on Ethanol Consumption Using a Limited Access Procedure in the Rat
Stromberg, M. F., Volpicelli, J. R., & O'Brien, C. P. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb05932.x · Cited by 63
Self-citation
Enhanced sensitivity of the nucleus accumbens proenkephalin system to alcohol in rats selectively bred for alcohol preference
Li, X.-W., Li, T., & Froehlich, J. C. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00191-7 · Cited by 61
Regional cerebral blood flow changes in chronic alcoholic patients induced by naltrexone challenge during detoxification.
Catafau, A. M., Etcheberrigaray, A., Cobos, J. P. D. L., Estorch, M., Guardia, J., Flotats, A., Bernà, L., Aparici, C. M., Casas, M., & Carrió, I. (1999) · PubMed · Cited by 63
The effects of acamprosate on alcohol-cue reactivity and alcohol priming in dependent patients: a randomized controlled trial
Hammarberg, A., Jayaram‐Lindström, N., Beck, O., Franck, J., & Reid, M. S. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1515-6 · Cited by 62
Ethanol Consumption by Fawn‐Hooded Rats Following Abstinence Effect of Naltrexone and Changes in μ‐Opioid Receptor Density
Cowen, M. S., Rezvani, A. H., Jarrott, B., & Lawrence, A. J. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04218.x · Cited by 62
NALTREXONE IN THE TREATMENT OF ALCOHOLISM
Weinrieb, R. M., & O’Brien, C. P. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.477 · Cited by 62
Advances in Non-Nicotine Pharmacotherapy for Smoking Cessation
Covey, L. S., Sullivan, M. A., Johnston, J. A., Glassman, A. H., Robinson, M. D., & Adams, D. P. (2000) · Drugs · doi:10.2165/00003495-200059010-00003 · Cited by 62

Authors: Volpicelli, J. R.
Affiliations: University of Pennsylvania (US)
Corresponding author: Volpicelli, Joseph R.
ORCID: Volpicelli, Joseph R.
Venue: Archives of General Psychiatry
Publisher: American Medical Association (AMA)
Published: 1992-11-01
Volume: 49
Issue: 11
Pages: 876
ISSN: 0003-990X (ISSN-L)
DOI: 10.1001/archpsyc.1992.01820110040006
OpenAlex: W2104538950
Cited by: 1,828
References: 23
Citations by year: 2026: 7 · 2025: 10 · 2024: 17 · 2023: 15 · 2022: 25 · 2021: 17 · 2020: 28 · 2019: 26 · 2018: 29 · 2017: 26 · 2016: 32 · 2015: 48 · 2014: 49 · 2013: 47 · 2012: 58
FWCI: 36.57
Type: journal article
Language: en
Open access: closed
Locations: Archives of General Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Alcohol Abuse and Alcoholism (AA0751701A1)
National Institute on Drug Abuse (DA-05186)
Topics: Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
Keywords: naltrexone, alcoholism, alcohol craving, alcohol relapse prevention, alcohol detoxification, outpatient care, opioid antagonists, adjunct pharmacotherapy, nausea, arthritic pain
MeSH terms: Adult, Alcohol Drinking, Alcoholism, Ambulatory Care, Combined Modality Therapy, Double-Blind Method, Humans, Male, Naltrexone, Nausea, Patient Dropouts, Placebos, Psychiatric Status Rating Scales, Psychotherapy, Recurrence, Severity of Illness Index, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Naltrexone in the Treatment of Alcohol Dependence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks